Evidence map›Paper›PMID 40555397›Full record

ArticleBritish journal of pharmacology2025

Unravelling the multifaceted actions of neurosteroids: Machine learning and in vitro screening for novel target discovery.

Ajeet Kumar, Mingxing Qian, Yuanjian Xu, Ann Benz, Douglas F Covey, Charles F Zorumski, Steven Mennerick

Abstract read
In one paragraph

Article in British journal of pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. New directions in neurosteroid therapeutics in neuropsychiatry.Neuroscience and biobehavioral reviews · 2025
    Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Ajeet KumarDepartment of Psychiatry, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.ORCID https://orcid.org/0000-0002-8818-3539
Mingxing QianDepartment of Developmental Biology, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Yuanjian XuDepartment of Developmental Biology, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Ann BenzDepartment of Psychiatry, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Douglas F CoveyDepartment of Psychiatry, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Charles F ZorumskiDepartment of Psychiatry, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Steven MennerickDepartment of Psychiatry, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.ORCID https://orcid.org/0000-0003-0868-0664

Funding

Neuroactive steroids as novel psychiatric treatments: mechanistic studiesP50MH122379 · NIMH · WASHINGTON UNIVERSITY · PI EVERS, ALEX S. · 2021 to 2025
$12.2M
GABAA RECEPTOR POPULATIONS IN HIPPOCAMPUS AND THALAMUSR01MH123748 · NIMH · WASHINGTON UNIVERSITY · PI MENNERICK, STEVEN J · 2021 to 2025
$2.4M
NIMH NIH HHS MH122379NIMH NIH HHS MH123748NIMH NIH HHS P50 MH122379NIMH NIH HHS R01 MH123748Taylor Family Institute for Innovative Psychiatric Research, School of Medicine, Washington University in St. Louis
6 · The paper itself

Abstract

background and purposeNeurosteroids (NS) modulate neuronal function and are promising therapeutic agents for neuropsychiatric disorders. NS analogues are approved for treating postpartum depression and are of interest in other disorders. Gamma-aminobutyric acid type A (GABA EXPERIMENTAL APPROACH: We performed hypothesis-generating in silico analyses using machine learning and broad in vitro biological screens to assess the range of actions of NS analogues of varying structural attributes. We employed machine learning for molecular similarity analysis and network pharmacology to elucidate likely targets. KEY

resultsThis analysis confirmed likely targets beyond GABA CONCLUSIONS AND IMPLICATIONS: NS compounds are ascendant treatments in neuropsychiatry, but their full spectrum of actions remains unclear. This virtual and biological screening discovery approach opens new vistas for exploring the mechanism of NS analogues. The multifaceted approach provides an unbiased, holistic exploration of the potential effects of NS compounds across various molecular targets and provides a platform for future validation studies to aid drug discovery.

Indexed as

Drug DiscoveryMachine LearningNeurosteroidsAnimalsHumansReceptors, GABA-ANeurosteroidsReceptors, GABA-Akinasesneurosteroidsneurotherapeuticreceptorssignalling

Identifiers

PMID40555397
PMCPMC13531688

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.